Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chipotle (CMG) upgraded to Equal Weight from Underweight at Stephens by analyst Will Slabaugh, as he believes that sentiment is likely close to a bottom. He is cautious on competition and near-term cost pressures, but thinks the launch of queso and improved marketing can improve trends. 2. Vornado (VNO) upgraded to Buy from Hold at Argus by analyst Jacob Kilstein, who said he expects results to benefit from the recent spinoff of the struggling Washington D.C. segment. The analyst added that, despite rising supply in New York, he believes demand remains solid and expects the company to raise rents in this market and notes shares have underperformed the S&P 500 by 5% over the last three months. 3. Intra-Cellular (ITCI) upgraded to Outperform from Market Perform JMP Securities by analyst Jason Butler, who believes that upcoming data on the company's lumateperone treatment for schizophrenia could significantly lower the risk facing the drug. 4. PetMed Express (PETS) upgraded to Buy from Neutral at Sidoti by analyst Anthony Lebiedzinski, who said he believes recent share pressure from "overdone" competitive concerns and yesterday's short report on the stock have created an attractive entry point with the company's fundamental outlook still bright. 5. Gentex (GNTX) upgraded to Outperform from Neutral at Baird by analyst David Leiker, citing its year-to-date underperformance. He believes its business model and growth from rising mirror penetration is more durable than investors perceive. Coupled with the strongest portfolio of incremental electronic features in the company's history, it expands the addressable content opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
click here.